Systemic inflammatory response index is a  prognostic biomarker in unresectable pancreatic adenocarcinoma and identifies patients for more intensive treatment

ConclusionOur study suggests that SIRI is able to predict OS in patients with PDAC. Patients with high SIRI values treated with platinum-based chemotherapy achieved longer OS than those treated with gemcitabine-based regimens.
Source: Memo - Magazine of European Medical Oncology - Category: Cancer & Oncology Source Type: research